This is the first time the NDRC has fined a device maker, according to the report.
The China Economic Herald — the official publication of the NDRC — said Medtronic is just the “tip of the iceberg,” claiming the regulatory body is monitoring 100 other drug companies and device makers.
According to WSJ, a Medtronic spokesperson said the company accepted the decision and plans to pay the fine.
More articles on supply chain:
Survey: 48% of U.S. manufacturers list unqualified workers as largest barrier to growth
Opinion: Why supply chain execs must take the lead in stopping climate change
Express Scripts stock tumbles 9% after short-seller’s ‘take-down’ tweet
